The interesting insights on the role of PRL3 in deregulating cellular metabolism warrants further study, especially given the seemingly contradictory findings, which are likely because existing studies have been limited to one cancer type (MM). This evidence concerns the gene PTP4A3 and Miyoshi myopathy.